Status | Study |
Not yet recruiting |
Study Name: Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2017-03-16 Interventions: Other: adverse events using patient-reported outcomes version of common term |
Recruiting |
Study Name: A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application Condition: Nasopharyngeal Neoplasms Date: 2016-11-30 Interventions: Other: CAR-T cells the patients treat with CAR-T cells |
Recruiting |
Study Name: A Trial of Endostar in Patients With Carcinoma of the Head and Neck Condition: Nasopharyngeal Neoplasms Date: 2016-08-12 Interventions: Drug: Endostar The patients will be randomized to CRT arm and CRT+Endostar arm. All patients will receiv |
Recruiting |
Study Name: ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy Condition: Nasopharyngeal Neoplasms Date: 2016-08-01 Interventions: Drug: Apatinib Patients will t |
Recruiting |
Study Name: Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2015-12-03 Interventions: Radiation: IMRT using individualized CTV |
Completed |
Study Name: The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients Condition: Nasopharyngeal Neoplasms Date: 2015-07-20 Interventions: Other: the number of circulating tumor cells |
Enrolling by invitation |
Study Name: A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2015-04-07 Interventions: Drug: endostar Other Name: Hum |
Completed |
Study Name: Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2015-02-03 Interventions: Drug: Docetaxel 75mg/㎡, |
Active, not recruiting |
Study Name: Safety and Efficacy of Oral Azacitidine in Previously Treated Subjects With Locally Advanced or Metastatic Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2014-10-17 Interventions: Drug: CC-486 Other Name: oral azacitidine |
Recruiting |
Study Name: Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2014-08-26 Interventions: Drug: Paclitaxel Paclitaxel 17 |